Risks of testosterone therapy in elderly men

Testosterone supplementation therapy (TST) is a widely used treatment for men with late onset hypogonadism. The benefits seen with TST, such as improved libido and energy level, beneficial effects on bone density have been well documented. Although hypogonadism remains an independent risk factor for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramasamy, Ranjith, Dupree, James M., Kovac, Jason R., Lipshultz, Larry I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2014
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901445/
https://www.ncbi.nlm.nih.gov/pubmed/24555118
http://dx.doi.org/10.12688/f1000research.3-11.v1
_version_ 1782300849865752576
author Ramasamy, Ranjith
Dupree, James M.
Kovac, Jason R.
Lipshultz, Larry I.
author_facet Ramasamy, Ranjith
Dupree, James M.
Kovac, Jason R.
Lipshultz, Larry I.
author_sort Ramasamy, Ranjith
collection PubMed
description Testosterone supplementation therapy (TST) is a widely used treatment for men with late onset hypogonadism. The benefits seen with TST, such as improved libido and energy level, beneficial effects on bone density have been well documented. Although hypogonadism remains an independent risk factor for mortality, recent studies have examined the association between testosterone therapy and cardiovascular risk.
format Online
Article
Text
id pubmed-3901445
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-39014452014-01-28 Risks of testosterone therapy in elderly men Ramasamy, Ranjith Dupree, James M. Kovac, Jason R. Lipshultz, Larry I. F1000Res Correspondence Testosterone supplementation therapy (TST) is a widely used treatment for men with late onset hypogonadism. The benefits seen with TST, such as improved libido and energy level, beneficial effects on bone density have been well documented. Although hypogonadism remains an independent risk factor for mortality, recent studies have examined the association between testosterone therapy and cardiovascular risk. F1000Research 2014-01-15 /pmc/articles/PMC3901445/ /pubmed/24555118 http://dx.doi.org/10.12688/f1000research.3-11.v1 Text en Copyright: © 2014 Ramasamy R et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/publicdomain/zero/1.0/ Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
spellingShingle Correspondence
Ramasamy, Ranjith
Dupree, James M.
Kovac, Jason R.
Lipshultz, Larry I.
Risks of testosterone therapy in elderly men
title Risks of testosterone therapy in elderly men
title_full Risks of testosterone therapy in elderly men
title_fullStr Risks of testosterone therapy in elderly men
title_full_unstemmed Risks of testosterone therapy in elderly men
title_short Risks of testosterone therapy in elderly men
title_sort risks of testosterone therapy in elderly men
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901445/
https://www.ncbi.nlm.nih.gov/pubmed/24555118
http://dx.doi.org/10.12688/f1000research.3-11.v1
work_keys_str_mv AT ramasamyranjith risksoftestosteronetherapyinelderlymen
AT dupreejamesm risksoftestosteronetherapyinelderlymen
AT kovacjasonr risksoftestosteronetherapyinelderlymen
AT lipshultzlarryi risksoftestosteronetherapyinelderlymen

Ejemplares similares